Niels Asger Jakobsen, BM BCh MRCP^1,2,3*, Sven Turkalj^1,3*, Bilyana Stoilova, PhD^1,4*, Marlen Metzner, MSc^1,3*, Rachel Moore, BA^1*, Batchimeg Usukhbayar^1*, Mirian Angulo Salazar, MSc^1*, Alison Kennedy, MSc^1,5*, Simon Newman^6,7*, Benjamin Kendrick^6,7*, Adrian Taylor^6,7*, Rasheed Afinowi-Luitz^6*, Roger Gundle^6,7*, Bridget Watkins^7*, Kim Wheway^7*, Debra Beazley^7*, Andrew Carr, ChM DSc FRCS FMedSci^7* and Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath^1,2,3

¹MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
²Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
³Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
⁴Department of Paediatrics, University of Oxford, Oxford, United Kingdom
⁵Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
⁶Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁷Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom

Lachelle D. Weeks, MD, PhD^1,2,3, Abhishek Niroula, PhD^1,4,5*, Donna S. Neuberg, ScD⁶, Waihay J. Wong, MD, PhD^7*, R. Coleman Lindsley^3,8, Marlise R. Luskin, MD^1,3, Nancy Berliner, MD^3,9, Richard M. Stone, MD^3,10, Daniel J DeAngelo, MD, PhD^3,10, Robert J Soiffer, MD^3,11,12, Md Mesbah Uddin, MSc, PhD^13,14*, Christopher J. Gibson, MD^1,3, Alexander G. Bick, MD, PhD^15*, Gabriel K. Griffin, MD^16,17, Siddhartha Jaiswal, MD¹⁸, Luca Malcovati, MD^19,20, Pradeep Natarajan, MD^13,21* and Benjamin L. Ebert, MD, PhD^1,5,22,23,24

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Center for Prevention of Progression, Dana-Farber Cancer Institute, Boston, MA
³Department of Medicine, Harvard Medical School, Boston, MA
⁴Department of Laboratory Medicine, Lund University, Lund, Sweden
⁵Broad Institute of MIT and Harvard University, Cambridge, MA
⁶Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁷Department of Pathology, Brigham and Women's Hospital, Boston, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
¹⁰Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹¹Division of Stem Cell Transplant and Cellular Therapies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹²Center for Prevention of Progression, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹³Cardiovascular Disease Research Center, Massachusetts General Hospital, Boston, MA
¹⁴Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
¹⁵Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
¹⁶Department of Pathology, Dana-Farber Cancer Institute, Boston, MA
¹⁷Department of Pathology, Brigham and Women's Hospital, Newton, MA
¹⁸Department of Pathology, Stanford University, Stanford, CA
¹⁹Department of Molecular Medicine, University of Pavia, Pavia, Italy
²⁰Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
²¹Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
²²Harvard Medical School, Boston, MA
²³Howard Hughes Medical Institute, Boston, MA
²⁴Dana-Farber Cancer Institute, Boston, MA

Hidetaka Uryu^1*, Koichi Saeki, PhD^2*, Jyoti Nangalia, MBBChir³, Michael Spencer Chapman, MBBS^4*, Li Zhao, PhD^5*, Joanne I. Hsu, MD, PhD^6,7,8*, Carlos E. Bueso-Ramos, MD, PhD^9,10,11, Shujuan Chen^12*, Hui Yang, MD, PhD¹³, Hagop Kantarjian, MD¹⁴, Courtney D. DiNardo, MD, MSCE¹³, Naval Daver, MD¹³, Simona Colla, PhD^15*, Irene Ganan-Gomez, PhD¹³, Jianhua Zhang, PhD^5*, Xingzhi Song, PhD^16*, Erika Thompson, MS^17*, Hongli Tang^17*, Robert Z. Orlowski, MD, PhD¹⁸, Richard E Champlin, MD¹⁹, Muzaffar H Qazilbash, MD¹⁹, Elizabeth J Shpall, MD¹⁹, Guillermo Garcia-Manero, MD²⁰, Hiroshi Haeno, PhD.^21*, Andrew Futreal, PhD^12* and Koichi Takahashi, MD, PhD²²

¹Leukemia Department, The UNIVERSITY of TEXAS, M.D. Anderson, Houston, TX
²The University of Tokyo, Graduate School of Frontier Sciences, Kashiwa, Japan
³Wellcome Sanger Institute, Saffron Walden, ENG, United Kingdom
⁴Department of Haematology, Department of Haematology, London, ENG, United Kingdom
⁵Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Medical Scientist Training Program, Baylor College of Medicine, Houston
⁷Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston
⁸Harvard Medical School, Boston, MA
⁹Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Leukemia Department, MD Anderson Cancer Center, Houston, TX
¹²Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁶Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁸Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²¹Division of Integrated Research Research, Institute for Biomedical Sciences, Tokyo University of Science, Noda, Japan
²²Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Niklas Landberg, MD, PhD^1*, Thomas Koehnke, MD, PhD², Yusuke Nakauchi, MD, PhD², Amy Fan^2*, Daiki Karigane, MD, PhD^2*, Daniel Thomas, MD, PhD³ and Ravindra Majeti, MD, PhD²

¹Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Lund, Skåne, Sweden
²Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
³Adelaide Medical School, University of Adelaide,, The University of Adelaide, Adelaide, SA, Australia

Janghee Woo, MD, PhD¹, Darlene Lu, PhD^1*, Andrew Lewandowski, PhD^1*, Paul M. Ridker, MD, MPH^2*, Benjamin L. Ebert, MD, PhD³ and David Steensma, MD^1*

¹Novartis Institutes for BioMedical Research, Cambridge, MA
²Cardiovascular Division, Brigham and Women's Hospital, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA

Zoe McQuilten, MBBS, PhD^1,2*, Nicholas C. Wong, BSc (Hons) PhD^3*, Anna Leichter, BSc^4*, Le T.P. Thao, PhD^5*, James Phung, BSc^5*, Andrew J Murphy, BSc PhD^6*, Moeen Riaz, BS PhD^5*, Robert Sebra, PhD^7*, Alexander G. Bick, MD, PhD^8*, John J. McNeil, MBBS PhD^5*, Rory Wolfe, PhD^5*, Robyn L. Woods, BSc (Hons) PhD^5*, Paul Lacaze, PhD^5*, Erica M. Wood, MBBS, FRACP, FRCPA^9,10 and David J. Curtis, MBBS, PhD¹¹

¹School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
²Monash Health, Melbourne, Australia
³Monash Bioinformatics Platform, Monash University, Melbourne, Australia
⁴Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
⁵Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
⁶Haematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, Australia
⁷Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
⁹Department of Clinical Haematology, Monash Health, Melbourne, VIC, Australia
¹⁰Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹¹Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia